Literature DB >> 16081484

Nitric oxide blunts the endothelin-mediated pulmonary vasoconstriction in exercising swine.

Birgit Houweling1, Daphne Merkus, Marjolein M D Dekker, Dirk J Duncker.   

Abstract

We have previously shown that vasodilators and vasoconstrictors that are produced by the vascular endothelium, including nitric oxide (NO), prostanoids and endothelin (ET), contribute to the regulation of systemic and pulmonary vascular tone in swine, in particular during treadmill exercise. Since NO and prostanoids can modulate the release of ET, and vice versa, we investigated the integrated endothelial control of pulmonary vascular resistance in exercising swine. Specifically, we tested the hypothesis that increased NO and prostanoid production during exercise limits the vasoconstrictor influence of ET, so that loss of these vasodilators results in exaggerated ET-mediated vasoconstriction during exercise. Fifteen instrumented swine were exercised on a treadmill at 0-5 km h(-1) before and during ET(A)/ET(B) receptor blockade (tezosentan, 3 mg kg(-1) I.V.) in the presence and absence of inhibition of NO synthase (N(omega)-nitro-L-arginine, 20 mg kg(-1) I.V.) and/or cyclo-oxygenase (indometacin, 10 mg kg(-1) I.V.). In the systemic circulation, ET receptor blockade decreased vascular resistance at rest, which waned with increasing exercise intensity. Prior inhibition of either NO or prostanoid production augmented the vasodilator effect of ET receptor blockade, and these effects were additive. In contrast, in the pulmonary bed, ET receptor blockade had no effect under resting conditions, but decreased pulmonary vascular resistance during exercise. Prior inhibition of NO synthase enhanced the pulmonary vasodilator effect of ET receptor blockade, particularly during exercise, whereas inhibition of prostanoids had no effect, even after prior NO synthase inhibition. In conclusion, endogenous endothelin limits pulmonary vasodilatation in response to treadmill exercise. This vasoconstrictor influence is blunted by NO but not by prostanoids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081484      PMCID: PMC1474726          DOI: 10.1113/jphysiol.2005.094227

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  34 in total

Review 1.  Crosstalk between endothelin and nitric oxide in the control of vascular tone.

Authors:  M Lavallée; M Takamura; R Parent; E Thorin
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system.

Authors:  K E Wiley; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Bosentan therapy for pulmonary arterial hypertension.

Authors:  Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael Landzberg; Gerald Simonneau
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

4.  Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Authors:  R N Channick; G Simonneau; O Sitbon; I M Robbins; A Frost; V F Tapson; D B Badesch; S Roux; M Rainisio; F Bodin; L J Rubin
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

5.  Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.

Authors:  M Max; R Kuhlen; R Dembinski; R Rossaint
Journal:  Intensive Care Med       Date:  1999-10       Impact factor: 17.440

6.  Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O(2)-consumption in exercising swine.

Authors:  D J Duncker; R Stubenitsky; P A Tonino; P D Verdouw
Journal:  Cardiovasc Res       Date:  2000-09       Impact factor: 10.787

Review 7.  Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension.

Authors:  V Hampl; J Herget
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

8.  Role of K(ATP)(+) channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine.

Authors:  D J Duncker; H H Oei; F Hu; R Stubenitsky; P D Verdouw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

9.  Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertension.

Authors:  Stephen J Wort; Mandy Woods; Timothy D Warner; Timothy W Evans; Jane A Mitchell
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

Review 10.  The nitric oxide-endothelin-1 connection.

Authors:  David Alonso; Marek W Radomski
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

View more
  9 in total

1.  Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.

Authors:  Birgit Houweling; Daphne Merkus; Oana Sorop; Frans Boomsma; Dirk J Duncker
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

2.  Alterations in endothelial control of the pulmonary circulation in exercising swine with secondary pulmonary hypertension after myocardial infarction.

Authors:  Daphne Merkus; Birgit Houweling; Vincent J de Beer; Zaida Everon; Dirk J Duncker
Journal:  J Physiol       Date:  2007-02-08       Impact factor: 5.182

3.  Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation.

Authors:  Jing-Xiang Wu; Hong-Wei Zhu; Xu Chen; Jiong-Lin Wei; Xiao-Feng Zhang; Mei-Ying Xu
Journal:  Inflamm Res       Date:  2014-04-24       Impact factor: 4.575

4.  Reduced contribution of endothelin to the regulation of systemic and pulmonary vascular tone in severe familial hypercholesterolaemia.

Authors:  Shawn B Bender; Vincent J de Beer; Darla L Tharp; Elza D van Deel; Douglas K Bowles; Dirk J Duncker; M Harold Laughlin; Daphne Merkus
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

5.  Pulmonary vasoconstrictor influence of endothelin in exercising swine depends critically on phosphodiesterase 5 activity.

Authors:  Zhichao Zhou; Vincent J de Beer; Daphne de Wijs-Meijler; Shawn B Bender; Maaike Hoekstra; M Harold Laughlin; Dirk J Duncker; Daphne Merkus
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-10       Impact factor: 5.464

6.  Sex differences in pulmonary vascular control: focus on the nitric oxide pathway.

Authors:  Daphne P M de Wijs-Meijler; A H Jan Danser; Irwin K M Reiss; Dirk J Duncker; Daphne Merkus
Journal:  Physiol Rep       Date:  2017-06

7.  Transition from post-capillary pulmonary hypertension to combined pre- and post-capillary pulmonary hypertension in swine: a key role for endothelin.

Authors:  Richard W B van Duin; Kelly Stam; Zongye Cai; André Uitterdijk; Ana Garcia-Alvarez; Borja Ibanez; A H Jan Danser; Irwin K M Reiss; Dirk J Duncker; Daphne Merkus
Journal:  J Physiol       Date:  2018-06-21       Impact factor: 5.182

8.  [Descriptive and comparative study of cardiovascular risk factors and physical activity in patients with acute coronary syndrome].

Authors:  Maria Isabel Vazquez-Arce; Elena Marques-Sule
Journal:  Aten Primaria       Date:  2017-08-23       Impact factor: 1.137

9.  Changes in the nitric oxide pathway of the pulmonary vasculature after exposure to hypoxia in swine model of neonatal pulmonary vascular disease.

Authors:  Daphne P M de Wijs-Meijler; Dirk J Duncker; A H Jan Danser; Irwin K M Reiss; Daphne Merkus
Journal:  Physiol Rep       Date:  2018-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.